<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Tools for genetics and genomics: Specially bred and genetically engineered mice</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Tools for genetics and genomics: Specially bred and genetically engineered mice</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Tools for genetics and genomics: Specially bred and genetically engineered mice</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert D Blank, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Benjamin A Raby, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer S Tirnauer, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Laboratory mice are among the most widely used model systems in biomedical research.</p><p>This topic discusses a subset of mouse resources and methods that support common and important research that is largely confined to mice. These include transgenic, knockout, knock-in, lineage tracing and pathway reporting strains, and immunodeficient and humanized mice. </p><p>Many other genetically engineered and specially bred mice are foundational for biomedical research but are beyond the scope of this document. Interested readers can find links to freely available educational materials curated by the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fresources.jax.org%2Fcontent-mini-courses&amp;token=FKk42w5%2Ffulal02ZHMAjw2oUlg0%2FWHLCa9BK3NDGUFNqw3K7aNn%2Bxy5wtMvDxG7Sd7WSthb9FXiOODJgVYJG7Q%3D%3D&amp;TOPIC_ID=2894" target="_blank">Jackson Laboratory</a>. </p><p>Other model systems for studying human disease are discussed separately (eg, yeast, worm, fruit fly, zebrafish). (See  <a class="medical medical_review" href="/z/d/html/2903.html" rel="external">"Tools for genetics and genomics: Model systems"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">TECHNICAL UNDERPINNINGS AND GENOME EDITING</span><span class="headingEndMark"> — </span>The fundamental technology at the core of most genetically engineered mice is the ability to introduce foreign DNA into pluripotent recipient cells. In practice, this is accomplished either by direct microinjection of DNA into a fertilized egg  (<a class="graphic graphic_picture graphicRef77166" href="/z/d/graphic/77166.html" rel="external">picture 1</a>), or by transfection into mouse embryonic stem (ES) cells (pluripotent cells that can give rise to all tissues, including the germline) [<a href="#rid1">1-3</a>]. (See  <a class="medical medical_review" href="/z/d/html/14598.html" rel="external">"Overview of stem cells", section on 'Embryonic stem (ES) cells'</a>.)</p><p>ES cells can be grown in culture and subjected to transfection and selection in the same manner as other cultured cells. ES cells shown to harbor the desired construct are then injected into mouse blastocysts to yield chimeric embryos. The blastocysts can then be implanted into foster mothers and the pregnancy carried to term.</p><p>Notable technical advances have occurred in genome editing, including the use of zinc finger nucleases, transcription activator-like effector nucleases (TALENs), and the CRISPR/Cas system [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/98724.html" rel="external">"Overview of gene therapy, gene editing, and gene silencing", section on 'Gene editing'</a>.)</p><p>These tools have greatly reduced the time and expense of creating knockout and knock-in animals. (See <a class="local">'Knockout mice'</a> below and <a class="local">'Knock-in mice'</a> below.)</p><p class="headingAnchor" id="H3637890803"><span class="h1">TYPES OF GENETICALLY ENGINEERED MICE</span></p><p class="headingAnchor" id="H13"><span class="h2">Transgenic mice</span><span class="headingEndMark"> — </span>Transgenic mice are those into which foreign DNA has been incorporated into the genome. According to this broad definition, all types of genetically engineered mice are transgenic. In a narrower sense, transgenic mice have an "extra" gene introduced to accomplish any of several experimental objectives:</p><p class="bulletIndent1"><span class="glyph">●</span>To correct pathology caused by mutation, thus proving that the transgene complements the preexisting mutation [<a href="#rid5">5</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>To introduce a reporter gene under specified genetic control to identify tissues and times at which the included control is active [<a href="#rid6">6-8</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>To introduce an abnormal gene, thus creating a disease model [<a href="#rid9">9</a>]</p><p></p><p>Simple transgenics, in which no attempt is made to target the construct to a specific site in the genome, can be generated by microinjecting DNA directly into one of the pronuclei of fertilized eggs in vitro. Surviving blastocysts are implanted into foster mothers and pups analyzed for presence of the transgene. </p><p class="headingAnchor" id="H14"><span class="h2">Knockout mice</span><span class="headingEndMark"> — </span>In contrast to simple transgenic animals, knockout mice depend upon successful gene targeting to disrupt a specific gene [<a href="#rid10">10</a>]. This is achieved by using genetic selection to enrich transfected ES cells for successful targeting.  </p><p>The motivation for doing this is to study the consequences of loss of function of the targeted gene directly in vivo. In contrast to experiments using cultured cells, the knockout allows the consequences of target gene disruption to be evaluated in the context of whole-organism physiology. In this setting, it is possible to study physiological adaptation to the knockout and discover effects in tissues in which pathology might not have been suspected a priori. Comparison and contrast among knockout phenotypes for related target genes help to identify both the unique and redundant functions of their products.</p><p class="headingAnchor" id="H15"><span class="h2">Knock-in mice</span><span class="headingEndMark"> — </span>Knock-in mice are theoretically similar to knockout mice, with the important difference that an altered rather than a null version of the target gene is substituted for the naturally occurring allele. Knock-in technology allows examination of the effects of different mutations on the same gene. This is particularly informative if the mutations thought to cause human disease result in gain of function rather than loss of function (eg, oncogenes) or if the goal is to investigate a mutant in a single tissue. (See <a class="local">'Conditional systems'</a> below.)</p><p class="headingAnchor" id="H16"><span class="h2">Conditional systems</span><span class="headingEndMark"> — </span>Some gene disruptions are lethal or lethal too early in development to allow fruitful investigation of their consequences. Alternatively, sometimes an experiment seeks to define the role of a gene's expression within a single tissue or cell type. A variety of methods have been developed to address this class of problems.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inducible promotors</strong> – Modulating transgene expression can be achieved by placing the transgene under the transcriptional control of an inducible promoter. The bacterial <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a> resistance operon provides such a reagent system [<a href="#rid11">11-13</a>]. The investigator can then regulate transgene expression by titrating administration of tetracycline to the transgenic animals.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tissue-specific knockouts</strong> – A strategy by which knockout expression can be restricted is generation of tissue-specific knockouts. This approach exploits the ability of bacteriophage P1 Cre recombinase to mediate site-specific recombination at specific short sequence elements called loxP sites [<a href="#rid14">14</a>]. Two engineered mice must be produced to carry out such an experiment. One construct introduces the loxP sites into the target gene, flanking sufficient DNA so that its deletion will achieve the desired loss of target gene activity. The second construct, which can be a simple transgene, introduces a functional gene for Cre recombinase driven by a tissue-specific promoter. Mice homozygous for the target gene construct are then mated to mice harboring the tissue-specific Cre construct. Offspring receiving the construct (expected to be 50 percent of the progeny) will express Cre recombinase in a tissue-specific manner, leading to excision of the portion of the target gene flanked by the loxP sites, thus knocking out the gene in that tissue exclusively  (<a class="graphic graphic_figure graphicRef51486" href="/z/d/graphic/51486.html" rel="external">figure 1</a>) [<a href="#rid15">15,16</a>]. </p><p></p><p class="bulletIndent1">Collaborative projects in North America and in Europe have developed conditional knockout alleles for thousands of genes [<a href="#rid17">17-20</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chimeric systems</strong> – The extraembryonic tissues are important in early developmental steps including gastrulation. One group developed a method by which early embryos can be tetraploidized, and chimeric embryos produced from tetraploidized embryos and cultured ES cells [<a href="#rid21">21,22</a>]. Under these conditions, the tetraploid cells give rise exclusively to extraembryonic tissue, while the diploid ES cells produce all of the embryo proper. This approach allows investigators to overcome some early developmental defects, thus allowing later functions of the disrupted gene to be studied [<a href="#rid23">23,24</a>].</p><p></p><p class="headingAnchor" id="H1250687253"><span class="h2">Reporter mice</span><span class="headingEndMark"> — </span>A common application of transgenic technology is to introduce an easily assayed reporter. Early work used b-galactosidase as the reporter molecule, which can be used to generate a blue histochemical dye specifically in tissues where the gene is expressed, and targeted a locus, <em>Rosa26</em>, that allows ubiquitous expression and whose disruption is phenotypically silent [<a href="#rid25">25</a>]. Expression is restricted by use of a tissue-specific or lineage-specific Cre construct. (See <a class="local">'Conditional systems'</a> above.)</p><p>Subsequent work has increasingly relied on fluorescent reporters which allow high resolution and obviate the need for histochemical processing [<a href="#rid26">26-31</a>]. </p><p>Lineage tracing is a common application invoked by using a tissue-specific or lineage-specific Cre in combination with a reporter construct [<a href="#rid32">32</a>]. Its use to validate tissue-specificity of Cre activity is considered best practice [<a href="#rid33">33</a>]. Lineage tracing with more elaborate reporters is also used to perform dynamic studies [<a href="#rid8">8</a>]. Examples include:</p><p class="bulletIndent1"><span class="glyph">●</span>Investigating the healing of injured glomeruli [<a href="#rid34">34</a>] </p><p class="bulletIndent1"><span class="glyph">●</span>Demonstrating the existence of functionally distinct endosteal and periosteal mesenchymal stem cells [<a href="#rid35">35</a>]</p><p></p><p>Reporter mice can also identify the anatomic sites at which specific biologic pathways are active. As an example, the TOPGAL mouse expresses beta-galactosidase at sites of canonical Wnt signaling [<a href="#rid36">36</a>]; this allows investigators to identify the tissues in which the pathway is active. In a 2022 study, combinatorial expression of eight signaling pathways was proposed to account for all developmental cell fates [<a href="#rid37">37</a>] </p><p class="headingAnchor" id="H1551725148"><span class="h2">Humanized immunodeficient mice</span><span class="headingEndMark"> — </span>In spite of their many strengths as a model organism, mice cannot adequately recapitulate all the features of human biology. These limitations are particularly evident in studies of immune function, transplantation, infectious diseases, and tumor biology. In order to overcome these limitations, investigators have developed the ability to engraft human cells and tissues into mice. These so-called humanized mice rely on exploiting immunodeficient mice, which have long served as hosts for in vivo study of human tumors and as models for investigation of immune function. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nude mouse </strong>– The nude mouse (<em>Foxn1</em><em><sup>nu/nu</sup></em>) was first noted as a spontaneous mutant in 1962, initially recognized for being hairless and having a short lifespan [<a href="#rid38">38,39</a>]. Subsequent work revealed absence of the thymus, impaired T cell development, and ability to tolerate xenografts (tissues from other species) [<a href="#rid40">40,41</a>]. Nude mice have great historical importance, but contemporary humanized mice used to engraft human hematopoietic and immune cells are based on different mouse mutants.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elements of immunodeficiency</strong> – Humanized mice must have the following three principal elements of immunodeficiency to allow robust human immune and hematopoietic cell engraftment:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Disruption in the recombinational machinery necessary for immune cell differentiation, satisfied by loss of function of <em>PRKDC</em>, <em>RAG1</em>, or <em>RAG2</em>. </p><p></p><p class="bulletIndent2">Loss of function mutations of <em>PRKDC</em>, encoding the catalytic subunit of DNA-dependent protein kinase, result in defective repair of double-stranded DNA breaks, resistance to ionizing radiation, and VDJ rearrangement in B and T cells [<a href="#rid42">42</a>]. Prior work established the severe combined immunodeficiency (SCID<em>, PRKDC</em><em><sup>scid/scid</sup></em>) phenotype and demonstrated that SCID mice can serve as experimental hosts for engrafting human immune cells [<a href="#rid43">43-46</a>]. This property led to SCID mice rapidly becoming a widely used platform in hematological malignancy, infectious disease, and autoimmunity research, even before the molecular pathogenesis of the SCID mutation was understood. Two additional genes, encoding recombination activating genes 1 and 2<em> (RAG1</em> a<em>nd RAG2</em>), also are needed for VDJ rearrangement, and mice deficient in them show profound impairment of B and T cell maturation, and consequently, immunity [<a href="#rid47">47-50</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Disruption of the shared gamma subunit (encoded by <em>IL2RG</em>) of multiple interleukin receptors. This disruption causes X-linked severe combined immune deficiency (X-SCID) in humans and a similar phenotype in mice [<a href="#rid51">51-54</a>]. (See  <a class="medical medical_review" href="/z/d/html/3927.html" rel="external">"X-linked severe combined immunodeficiency (X-SCID)"</a>.)</p><p></p><p class="bulletIndent2">Loss of function mutatio<em>ns of IL2RG</em> interfere with high-affinity binding of multiple cytokines including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Carriage of a "human-like" allele of <em>SIRPA</em>, encoding signal regulatory protein alpha type 1 [<a href="#rid55">55,56</a>]. </p><p></p><p class="bulletIndent2">This protein is expressed on macrophages and mediates an inhibitory signal that prevents phagocytosis [<a href="#rid57">57</a>]. Non-obese diabetic (NOD) mice coincidentally harbor<em> </em>a polymorphism in <em>SIRPA</em> that resembles the human protein and thereby protects human cells. For this reason, many humanized mice feature a NOD genetic background, although a few strains have a Balb/c background, which also harbors a more favorable<em> SIRPA</em> allele [<a href="#rid58">58</a>]. A few strains have a C57BL/6 background together with <em>SIRPA </em>or CD47 alleles that allow human cell engraftment.</p><p></p><p class="bulletIndent1">More than 20 mouse strains and stocks capable of being humanized are available from the major commercial laboratory mouse vendors; descriptions can be found on their websites. Additional strains have been developed by individual laboratories.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Delivery of human cells</strong> – To generate humanized mice, an immunodeficient mouse must receive human donor cells. These can be delivered in several ways. Human peripheral blood mononuclear cells or human hematopoietic stem cells can be infused into host mice, which are typically irradiated prior to infusion [<a href="#rid44">44,46</a>]. Alternatively, fetal liver and thymus tissue can be placed under the renal capsule [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Engraftment</strong> – All of the existing mouse host strains and engraftment strategies display important limitations, and careful planning is necessary to choose the best system to study the relevant biology. Some common problems include development of graft-versus-host disease (GVHD), poor development of lymph nodes, poor maturation of lymphocytes, and limited survival of engrafted tissue. The many available recipient strains represent efforts by numerous investigators to overcome the biological constraints in the context of specific problems encountered in their research.</p><p></p><p class="headingAnchor" id="H17"><span class="h1">LIMITATIONS AND CAVEATS</span><span class="headingEndMark"> — </span>Limitations and caveats with genetically engineered mice include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unclear or mixed genetic background –</strong> Characteristics of different mouse strains are highly variable, so knowing the background in which a genetic construct has been studied is essential to interpreting its biology. For technical reasons, many genetically engineered mice have been generated on one of the 129 strains, which have been found to be more diverse than previously believed [<a href="#rid59">59-61</a>]. Investigators routinely breed founder animals to a recipient strain, most often C57BL/6. Consequently, the constructs are often studied on a poorly defined "mixed 129 X C57BL/6 background," without further information regarding the relative contributions of the progenitor genomes, number of generations of subsequent inbreeding, or often even the correct strain information regarding the progenitors. While unfortunate, this is the status of most of the extant literature. Efforts to improve reporting of strain background in the future are underway [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk of insertional mutagenesis</strong> – For mice in which the construct has not been targeted to a specific locus, incorporation of the transgene may result in insertional mutagenesis, with the resulting phenotype arising not from the transgene, but from disruption of the gene into which the transgene was placed [<a href="#rid63">63</a>]. The transgene's expression may also be variable according to the properties of the insertion site [<a href="#rid64">64</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Variation in expression levels</strong> – A third complication is that multiple copies of the transgene may be inserted into the genome, with consequent differences in transgene expression level. These limitations can be addressed by targeting transgenes to specific sites. One site that allows insertion of a single copy of the transgene while allowing transcription to be mediated by sequences included in the targeting vector is the HPRT locus, encoding the salvage purine utilization enzyme hypoxanthine/guanine phosphoribosyl transferase [<a href="#rid65">65,66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Challenges in defining causality</strong> – The major limitation of knockouts is that the allele generated is, by design, null. Therefore, while they are useful for establishing the role of the target gene in a pathway, it is not necessarily the case that mutations in the target gene account for human diseases or population variation in downstream phenotypes mediated by it. Knock-in strategies can address this by allowing study of a series of mutant alleles. By virtue of being targeted to the homologous locus, the issue of unintentional insertional mutation does not arise with knockout mice. </p><p></p><p class="bulletIndent1">The limitations related to strain background are significant, particularly because 129-related strains have been the source of many ES cell lines. More recent success in generating successful ES cells from other strains promises to mitigate this problem in the future [<a href="#rid67">67,68</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Off-target effects and Cre toxicity</strong> – Another difficulty is that Cre constructs are neither perfectly efficient nor perfectly specific. Thus, "tissue-specific" Cre constructs are sometimes active outside the target tissue, and Cre constructs presumed to be inducible are active in the absence of the inducing substance [<a href="#rid69">69,70</a>]. Furthermore, Cre constructs can exert inherent biological effects, including "Cre toxicity" and Cre-mediated suppression of tumor growth [<a href="#rid71">71-75</a>].</p><p></p><p>The practical response to these limitations is that when transgenic mice are generated, investigators routinely study animals derived from several different founders. The minimal characterization will generally include estimation of copy number, transgene mRNA level, and transgene protein level. More detailed analysis is then conducted on one or a small number of the transgenic lines. Appropriate and complete control groups need to be characterized in parallel. Careful investigators will also report the breeding history between founder and the analyzed animals.</p><p class="headingAnchor" id="H18"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic manipulations</strong> – The ability to introduce foreign DNA into pluripotent embryonic stem cells is at the core of most genetically engineered mice. Genome editing has greatly reduced the time and expense of creating transgenic animals. (See <a class="local">'Technical underpinnings and genome editing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Types of genetically engineered mice</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Transgenic mice are those into which foreign DNA has been incorporated into the genome. (See <a class="local">'Transgenic mice'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Knockout mice depend upon successful gene transfer targeted to disrupt a specific gene to study the consequences of loss of function of the targeted gene directly in vivo. (See <a class="local">'Knockout mice'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Knock-in technology allows examination of the effects of different mutations on the same gene. (See <a class="local">'Knock-in mice'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cre constructs driven by tissue-specific or lineage-specific promoters can restrict transgene disruption or expression to a defined cell population. (See <a class="local">'Conditional systems'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A variety of reporter constructs have permitted widespread adoption of lineage tracing strategies. (See <a class="local">'Reporter mice'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Immunodeficient mice can be reconstituted with human constructs to permit better modeling of disease-related research questions. (See <a class="local">'Humanized immunodeficient mice'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limitations and caveats</strong> – Investigators must consider potential issues related to the genetic background of the animals, risk of insertional mutagenesis, variable expression levels, challenges in defining causality based on gene knockout studies, and off-target effects and Cre toxicity. (See <a class="local">'Limitations and caveats'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bradley A, Evans M, Kaufman MH, Robertson E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984; 309:255.</a></li><li><a class="nounderline abstract_t">Robertson E, Bradley A, Kuehn M, Evans M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 1986; 323:445.</a></li><li><a class="nounderline abstract_t">Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981; 78:7634.</a></li><li><a class="nounderline abstract_t">Maggio I, Gonçalves MA. Genome editing at the crossroads of delivery, specificity, and fidelity. Trends Biotechnol 2015; 33:280.</a></li><li><a class="nounderline abstract_t">Hardin JD, Boast S, Mendelsohn M, et al. Transgenes encoding both type I and type IV c-abl proteins rescue the lethality of c-abl mutant mice. Oncogene 1996; 12:2669.</a></li><li><a class="nounderline abstract_t">Kalajzic I, Kalajzic Z, Kaliterna M, et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 2002; 17:15.</a></li><li><a class="nounderline abstract_t">Chai Y, Jiang X, Ito Y, et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000; 127:1671.</a></li><li><a class="nounderline abstract_t">Snippert HJ, van der Flier LG, Sato T, et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 2010; 143:134.</a></li><li><a class="nounderline abstract_t">Khillan JS, Olsen AS, Kontusaari S, et al. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J Biol Chem 1991; 266:23373.</a></li><li><a class="nounderline abstract_t">Mansour SL, Thomas KR, Capecchi MR. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 1988; 336:348.</a></li><li><a class="nounderline abstract_t">Fedorov LM, Tyrsin OY, Krenn V, et al. Tet-system for the regulation of gene expression during embryonic development. Transgenic Res 2001; 10:247.</a></li><li><a class="nounderline abstract_t">Bohl D, Heard JM. Modulation of erythropoietin delivery from engineered muscles in mice. Hum Gene Ther 1997; 8:195.</a></li><li><a class="nounderline abstract_t">Paulus W, Baur I, Boyce FM, et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70:62.</a></li><li><a class="nounderline abstract_t">Hoess RH, Ziese M, Sternberg N. P1 site-specific recombination: nucleotide sequence of the recombining sites. Proc Natl Acad Sci U S A 1982; 79:3398.</a></li><li><a class="nounderline abstract_t">Rajewsky K, Gu H, Kühn R, et al. Conditional gene targeting. J Clin Invest 1996; 98:600.</a></li><li><a class="nounderline abstract_t">Rossant J, McMahon A. "Cre"-ating mouse mutants-a meeting review on conditional mouse genetics. Genes Dev 1999; 13:142.</a></li><li><a class="nounderline abstract_t">Schnütgen F, De-Zolt S, Van Sloun P, et al. Genomewide production of multipurpose alleles for the functional analysis of the mouse genome. Proc Natl Acad Sci U S A 2005; 102:7221.</a></li><li><a class="nounderline abstract_t">Schnütgen F. Generation of multipurpose alleles for the functional analysis of the mouse genome. Brief Funct Genomic Proteomic 2006; 5:15.</a></li><li><a class="nounderline abstract_t">Floss T, Schnütgen F. Conditional gene trapping using the FLEx system. Methods Mol Biol 2008; 435:127.</a></li><li><a class="nounderline abstract_t">Friedel RH, Seisenberger C, Kaloff C, Wurst W. EUCOMM--the European conditional mouse mutagenesis program. Brief Funct Genomic Proteomic 2007; 6:180.</a></li><li><a class="nounderline abstract_t">Nagy A, Rossant J, Nagy R, et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 1993; 90:8424.</a></li><li class="breakAll">Nagy A, Rossant J. Production of completely ES cell-derived fetuses. In: Gene Targeting: A Practical Approach, Joyner AL (Ed), Oxford University Press, New York 1993. p.147.</li><li><a class="nounderline abstract_t">Duncan SA, Nagy A, Chan W. Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4(-/-) embryos. Development 1997; 124:279.</a></li><li><a class="nounderline abstract_t">Li J, Ning G, Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 2000; 14:464.</a></li><li><a class="nounderline abstract_t">Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21:70.</a></li><li><a class="nounderline abstract_t">Lobe CG, Koop KE, Kreppner W, et al. Z/AP, a double reporter for cre-mediated recombination. Dev Biol 1999; 208:281.</a></li><li><a class="nounderline abstract_t">Mao X, Fujiwara Y, Orkin SH. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci U S A 1999; 96:5037.</a></li><li><a class="nounderline abstract_t">Kawamoto S, Niwa H, Tashiro F, et al. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett 2000; 470:263.</a></li><li><a class="nounderline abstract_t">Novak A, Guo C, Yang W, et al. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 2000; 28:147.</a></li><li><a class="nounderline abstract_t">Mao X, Fujiwara Y, Chapdelaine A, et al. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 2001; 97:324.</a></li><li><a class="nounderline abstract_t">Srinivas S, Watanabe T, Lin CS, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001; 1:4.</a></li><li><a class="nounderline abstract_t">Kretzschmar K, Watt FM. Lineage tracing. Cell 2012; 148:33.</a></li><li><a class="nounderline abstract_t">Heffner CS, Herbert Pratt C, Babiuk RP, et al. Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat Commun 2012; 3:1218.</a></li><li><a class="nounderline abstract_t">Hackl MJ, Burford JL, Villanueva K, et al. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat Med 2013; 19:1661.</a></li><li><a class="nounderline abstract_t">Debnath S, Yallowitz AR, McCormick J, et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature 2018; 562:133.</a></li><li><a class="nounderline abstract_t">DasGupta R, Fuchs E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 1999; 126:4557.</a></li><li><a class="nounderline abstract_t">Huang Z. Simplifying cell fate map by determining lineage history of core pathway activation during fate specification. Trends Dev Biol 2022; 15:53.</a></li><li><a class="nounderline abstract_t">Isaacson JH, Cattanach BM. Two new 'hairless' mutants - Sha and Hfh11. Mouse News Lett 1962; 27:31.</a></li><li><a class="nounderline abstract_t">Flanagan SP. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res 1966; 8:295.</a></li><li><a class="nounderline abstract_t">Pantelouris EM. Absence of thymus in a mouse mutant. Nature 1968; 217:370.</a></li><li><a class="nounderline abstract_t">Rygaard J, Povlsen CO. Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand 1969; 77:758.</a></li><li><a class="nounderline abstract_t">Blunt T, Gell D, Fox M, et al. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci U S A 1996; 93:10285.</a></li><li><a class="nounderline abstract_t">Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527.</a></li><li><a class="nounderline abstract_t">Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335:256.</a></li><li><a class="nounderline abstract_t">McCune JM, Namikawa R, Kaneshima H, et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241:1632.</a></li><li><a class="nounderline abstract_t">Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988; 242:1706.</a></li><li><a class="nounderline abstract_t">Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell 1989; 59:1035.</a></li><li><a class="nounderline abstract_t">Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990; 248:1517.</a></li><li><a class="nounderline abstract_t">Mombaerts P, Iacomini J, Johnson RS, et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68:869.</a></li><li><a class="nounderline abstract_t">Shinkai Y, Rathbun G, Lam KP, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992; 68:855.</a></li><li><a class="nounderline abstract_t">Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73:147.</a></li><li><a class="nounderline abstract_t">DiSanto JP, Müller W, Guy-Grand D, et al. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A 1995; 92:377.</a></li><li><a class="nounderline abstract_t">Cao X, Shores EW, Hu-Li J, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995; 2:223.</a></li><li><a class="nounderline abstract_t">Ohbo K, Suda T, Hashiyama M, et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 1996; 87:956.</a></li><li><a class="nounderline abstract_t">Takenaka K, Prasolava TK, Wang JC, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007; 8:1313.</a></li><li><a class="nounderline abstract_t">Yamauchi T, Takenaka K, Urata S, et al. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood 2013; 121:1316.</a></li><li><a class="nounderline abstract_t">Yamao T, Noguchi T, Takeuchi O, et al. Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J Biol Chem 2002; 277:39833.</a></li><li><a class="nounderline abstract_t">Iwamoto C, Takenaka K, Urata S, et al. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment. Exp Hematol 2014; 42:163.</a></li><li><a class="nounderline abstract_t">Threadgill DW, Yee D, Matin A, et al. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm Genome 1997; 8:390.</a></li><li><a class="nounderline abstract_t">Simpson EM, Linder CC, Sargent EE, et al. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 1997; 16:19.</a></li><li><a class="nounderline abstract_t">Threadgill DW, Matin A, Yee D, et al. SSLPs to map genetic differences between the 129 inbred strains and closed-colony, random-bred CD-1 mice. Mamm Genome 1997; 8:441.</a></li><li><a class="nounderline abstract_t">Festing MF, Simpson EM, Davisson MT, Mobraaten LE. Revised nomenclature for strain 129 mice. Mamm Genome 1999; 10:836.</a></li><li><a class="nounderline abstract_t">Tutois S, Salaun J, Mattei MG, Guénet JL. Tg (9 HSA-MYC), a homozygous lethal insertion in the mouse. Mamm Genome 1991; 1:184.</a></li><li><a class="nounderline abstract_t">DeLoia JA, Solter D. A transgene insertional mutation at an imprinted locus in the mouse genome. Dev Suppl 1990; :73.</a></li><li><a class="nounderline abstract_t">Bronson SK, Plaehn EG, Kluckman KD, et al. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci U S A 1996; 93:9067.</a></li><li><a class="nounderline abstract_t">Misra RP, Bronson SK, Xiao Q, et al. Generation of single-copy transgenic mouse embryos directly from ES cells by tetraploid embryo complementation. BMC Biotechnol 2001; 1:12.</a></li><li><a class="nounderline abstract_t">Kitani H, Takagi N, Atsumi T, et al. Isolation of a germline-transmissible embryonic stem (ES) cell line from C3H/He mice. Zoolog Sci 1996; 13:865.</a></li><li><a class="nounderline abstract_t">Schuster-Gossler K, Lee AW, Lerner CP, et al. Use of coisogenic host blastocysts for efficient establishment of germline chimeras with C57BL/6J ES cell lines. Biotechniques 2001; 31:1022.</a></li><li><a class="nounderline abstract_t">Jeffery E, Berry R, Church CD, et al. Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte 2014; 3:206.</a></li><li><a class="nounderline abstract_t">Kristianto J, Johnson MG, Zastrow RK, et al. Spontaneous recombinase activity of Cre-ERT2 in vivo. Transgenic Res 2017; 26:411.</a></li><li><a class="nounderline abstract_t">Schmidt-Supprian M, Rajewsky K. Vagaries of conditional gene targeting. Nat Immunol 2007; 8:665.</a></li><li><a class="nounderline abstract_t">Loonstra A, Vooijs M, Beverloo HB, et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A 2001; 98:9209.</a></li><li><a class="nounderline abstract_t">Jeannotte L, Aubin J, Bourque S, et al. Unsuspected effects of a lung-specific Cre deleter mouse line. Genesis 2011; 49:152.</a></li><li><a class="nounderline abstract_t">Thanos A, Morizane Y, Murakami Y, et al. Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse. Am J Pathol 2012; 180:1917.</a></li><li><a class="nounderline abstract_t">Li Y, Choi PS, Casey SC, Felsher DW. Activation of Cre recombinase alone can induce complete tumor regression. PLoS One 2014; 9:e107589.</a></li></ol></div><div id="topicVersionRevision">Topic 2894 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6717601" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3762693" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6950406" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25819765" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Genome editing at the crossroads of delivery, specificity, and fidelity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8700526" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Transgenes encoding both type I and type IV c-abl proteins rescue the lethality of c-abl mutant mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11771662" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10725243" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20887898" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1744131" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3194019" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11437281" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Tet-system for the regulation of gene expression during embryonic development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9017423" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Modulation of erythropoietin delivery from engineered muscles in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8523582" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6954485" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : P1 site-specific recombination: nucleotide sequence of the recombining sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8698848" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Conditional gene targeting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9925637" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : "Cre"-ating mouse mutants-a meeting review on conditional mouse genetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15870191" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Genomewide production of multipurpose alleles for the functional analysis of the mouse genome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16769672" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Generation of multipurpose alleles for the functional analysis of the mouse genome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18370072" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Conditional gene trapping using the FLEx system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17967808" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : EUCOMM--the European conditional mouse mutagenesis program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8378314" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8378314" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9053305" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4(-/-) embryos.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10691738" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9916792" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Generalized lacZ expression with the ROSA26 Cre reporter strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10191045" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Z/AP, a double reporter for cre-mediated recombination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10220414" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10745079" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11105057" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11133778" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11299042" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22265400" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Lineage tracing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23169059" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24270544" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30250253" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Discovery of a periosteal stem cell mediating intramembranous bone formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10498690" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37396969" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Simplifying cell fate map by determining lineage history of core pathway activation during fate specification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Two new 'hairless' mutants - Sha and Hfh11</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5980117" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : 'Nude', a new hairless gene with pleiotropic effects in the mouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5639157" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Absence of thymus in a mouse mutant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5383844" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Heterotransplantation of a human malignant tumour to "Nude" mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8816792" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6823332" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A severe combined immunodeficiency mutation in the mouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2970594" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Transfer of a functional human immune system to mice with severe combined immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2971269" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2904703" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Engraftment of immune-deficient mice with human hematopoietic stem cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2598259" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The V(D)J recombination activating gene, RAG-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2360047" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1547488" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : RAG-1-deficient mice have no mature B and T lymphocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1547487" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8462096" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7831294" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7697543" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8562967" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17982459" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23293079" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12167615" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24269920" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9166580" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9140391" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9166591" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : SSLPs to map genetic differences between the 129 inbred strains and closed-colony, random-bred CD-1 mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10430671" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Revised nomenclature for strain 129 mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1797233" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Tg (9 HSA-MYC), a homozygous lethal insertion in the mouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2090433" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A transgene insertional mutation at an imprinted locus in the mouse genome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8799155" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Single-copy transgenic mice with chosen-site integration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11782291" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Generation of single-copy transgenic mouse embryos directly from ES cells by tetraploid embryo complementation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9107142" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Isolation of a germline-transmissible embryonic stem (ES) cell line from C3H/He mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11730008" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Use of coisogenic host blastocysts for efficient establishment of germline chimeras with C57BL/6J ES cell lines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25068087" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Characterization of Cre recombinase models for the study of adipose tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28409408" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Spontaneous recombinase activity of Cre-ERT2 in vivo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17579640" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Vagaries of conditional gene targeting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11481484" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21309069" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Unsuspected effects of a lung-specific Cre deleter mouse line.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22429967" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25208064" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Activation of Cre recombinase alone can induce complete tumor regression.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
